nodes	percent_of_prediction	percent_of_DWPC	metapath
Flutamide—CYP1B1—esophageal cancer	0.771	1	CbGaD
Flutamide—Metastatic neoplasm—Cisplatin—esophageal cancer	0.00483	0.0907	CcSEcCtD
Flutamide—Urine color abnormal—Capecitabine—esophageal cancer	0.0029	0.0544	CcSEcCtD
Flutamide—Necrolysis epidermal—Methotrexate—esophageal cancer	0.00224	0.042	CcSEcCtD
Flutamide—Chromaturia—Capecitabine—esophageal cancer	0.00191	0.0359	CcSEcCtD
Flutamide—Nodule—Methotrexate—esophageal cancer	0.00173	0.0325	CcSEcCtD
Flutamide—AHR—bronchus—esophageal cancer	0.00172	0.0836	CbGeAlD
Flutamide—AHR—smooth muscle tissue—esophageal cancer	0.00168	0.0818	CbGeAlD
Flutamide—AHR—trachea—esophageal cancer	0.00154	0.075	CbGeAlD
Flutamide—AHR—digestive system—esophageal cancer	0.00133	0.0646	CbGeAlD
Flutamide—AHR—lung—esophageal cancer	0.00111	0.0539	CbGeAlD
Flutamide—Loss of libido—Methotrexate—esophageal cancer	0.0011	0.0207	CcSEcCtD
Flutamide—Liver injury—Cisplatin—esophageal cancer	0.0011	0.0207	CcSEcCtD
Flutamide—Ulcer—Cisplatin—esophageal cancer	0.000979	0.0184	CcSEcCtD
Flutamide—Herpes zoster—Capecitabine—esophageal cancer	0.000906	0.017	CcSEcCtD
Flutamide—CYP1B1—smooth muscle tissue—esophageal cancer	0.000877	0.0426	CbGeAlD
Flutamide—AR—epithelium—esophageal cancer	0.000862	0.0419	CbGeAlD
Flutamide—AR—bronchus—esophageal cancer	0.000849	0.0412	CbGeAlD
Flutamide—AR—smooth muscle tissue—esophageal cancer	0.00083	0.0403	CbGeAlD
Flutamide—AHR—lymph node—esophageal cancer	0.000759	0.0369	CbGeAlD
Flutamide—Rectal haemorrhage—Capecitabine—esophageal cancer	0.000755	0.0142	CcSEcCtD
Flutamide—Haemolytic anaemia—Cisplatin—esophageal cancer	0.000744	0.014	CcSEcCtD
Flutamide—Ulcer—Capecitabine—esophageal cancer	0.000721	0.0135	CcSEcCtD
Flutamide—Interstitial lung disease—Methotrexate—esophageal cancer	0.000718	0.0135	CcSEcCtD
Flutamide—CYP1B1—digestive system—esophageal cancer	0.000692	0.0336	CbGeAlD
Flutamide—Pulmonary embolism—Capecitabine—esophageal cancer	0.000682	0.0128	CcSEcCtD
Flutamide—Herpes zoster—Methotrexate—esophageal cancer	0.000674	0.0127	CcSEcCtD
Flutamide—AR—digestive system—esophageal cancer	0.000655	0.0318	CbGeAlD
Flutamide—CYP1A1—epithelium—esophageal cancer	0.000643	0.0313	CbGeAlD
Flutamide—CYP1A1—bronchus—esophageal cancer	0.000633	0.0308	CbGeAlD
Flutamide—Ecchymosis—Capecitabine—esophageal cancer	0.000617	0.0116	CcSEcCtD
Flutamide—Neoplasm—Capecitabine—esophageal cancer	0.000617	0.0116	CcSEcCtD
Flutamide—CYP2C19—digestive system—esophageal cancer	0.000607	0.0295	CbGeAlD
Flutamide—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.000605	0.0114	CcSEcCtD
Flutamide—CYP1B1—lung—esophageal cancer	0.000578	0.0281	CbGeAlD
Flutamide—Diabetes mellitus—Capecitabine—esophageal cancer	0.000569	0.0107	CcSEcCtD
Flutamide—CYP1A1—trachea—esophageal cancer	0.000569	0.0276	CbGeAlD
Flutamide—Haemolytic anaemia—Capecitabine—esophageal cancer	0.000549	0.0103	CcSEcCtD
Flutamide—AR—lung—esophageal cancer	0.000547	0.0266	CbGeAlD
Flutamide—Ulcer—Methotrexate—esophageal cancer	0.000537	0.0101	CcSEcCtD
Flutamide—Libido decreased—Capecitabine—esophageal cancer	0.000534	0.01	CcSEcCtD
Flutamide—Hot flush—Capecitabine—esophageal cancer	0.000529	0.00994	CcSEcCtD
Flutamide—Increased appetite—Capecitabine—esophageal cancer	0.000527	0.0099	CcSEcCtD
Flutamide—Menopausal symptoms—Capecitabine—esophageal cancer	0.000525	0.00986	CcSEcCtD
Flutamide—Dermatitis bullous—Capecitabine—esophageal cancer	0.000518	0.00973	CcSEcCtD
Flutamide—Pulmonary embolism—Methotrexate—esophageal cancer	0.000508	0.00954	CcSEcCtD
Flutamide—Cystitis noninfective—Methotrexate—esophageal cancer	0.000496	0.00932	CcSEcCtD
Flutamide—CYP1A2—digestive system—esophageal cancer	0.000496	0.0241	CbGeAlD
Flutamide—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.000491	0.00923	CcSEcCtD
Flutamide—Cystitis—Methotrexate—esophageal cancer	0.00049	0.00921	CcSEcCtD
Flutamide—CYP1A1—digestive system—esophageal cancer	0.000489	0.0238	CbGeAlD
Flutamide—CYP3A5—digestive system—esophageal cancer	0.000478	0.0232	CbGeAlD
Flutamide—Ecchymosis—Methotrexate—esophageal cancer	0.000459	0.00862	CcSEcCtD
Flutamide—Bladder pain—Methotrexate—esophageal cancer	0.000459	0.00862	CcSEcCtD
Flutamide—Neoplasm—Methotrexate—esophageal cancer	0.000459	0.00862	CcSEcCtD
Flutamide—Gynaecomastia—Methotrexate—esophageal cancer	0.000454	0.00853	CcSEcCtD
Flutamide—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.000446	0.00838	CcSEcCtD
Flutamide—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.000446	0.00838	CcSEcCtD
Flutamide—Diabetes mellitus—Methotrexate—esophageal cancer	0.000424	0.00796	CcSEcCtD
Flutamide—CYP1A2—lung—esophageal cancer	0.000414	0.0201	CbGeAlD
Flutamide—CYP1A1—lung—esophageal cancer	0.000409	0.0199	CbGeAlD
Flutamide—Erythema—Cisplatin—esophageal cancer	0.000405	0.0076	CcSEcCtD
Flutamide—CYP3A5—lung—esophageal cancer	0.0004	0.0194	CbGeAlD
Flutamide—CYP1B1—lymph node—esophageal cancer	0.000395	0.0192	CbGeAlD
Flutamide—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000391	0.00734	CcSEcCtD
Flutamide—Hyperglycaemia—Capecitabine—esophageal cancer	0.000386	0.00725	CcSEcCtD
Flutamide—Ill-defined disorder—Cisplatin—esophageal cancer	0.000375	0.00705	CcSEcCtD
Flutamide—AR—lymph node—esophageal cancer	0.000374	0.0182	CbGeAlD
Flutamide—Anaemia—Cisplatin—esophageal cancer	0.000374	0.00702	CcSEcCtD
Flutamide—Jaundice—Capecitabine—esophageal cancer	0.000372	0.00699	CcSEcCtD
Flutamide—Malaise—Cisplatin—esophageal cancer	0.000365	0.00685	CcSEcCtD
Flutamide—Haematuria—Capecitabine—esophageal cancer	0.000364	0.00683	CcSEcCtD
Flutamide—Leukopenia—Cisplatin—esophageal cancer	0.000362	0.0068	CcSEcCtD
Flutamide—CYP3A4—digestive system—esophageal cancer	0.000359	0.0174	CbGeAlD
Flutamide—Anxiety—Cisplatin—esophageal cancer	0.000343	0.00645	CcSEcCtD
Flutamide—Hepatitis—Capecitabine—esophageal cancer	0.000343	0.00643	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000342	0.00642	CcSEcCtD
Flutamide—Discomfort—Cisplatin—esophageal cancer	0.00034	0.00639	CcSEcCtD
Flutamide—Oedema peripheral—Capecitabine—esophageal cancer	0.000338	0.00634	CcSEcCtD
Flutamide—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000332	0.00624	CcSEcCtD
Flutamide—Oedema—Cisplatin—esophageal cancer	0.00033	0.0062	CcSEcCtD
Flutamide—Thrombocytopenia—Cisplatin—esophageal cancer	0.000323	0.00607	CcSEcCtD
Flutamide—Skin disorder—Cisplatin—esophageal cancer	0.000321	0.00602	CcSEcCtD
Flutamide—Anorexia—Cisplatin—esophageal cancer	0.000315	0.00591	CcSEcCtD
Flutamide—Erythema—Capecitabine—esophageal cancer	0.000298	0.0056	CcSEcCtD
Flutamide—Erectile dysfunction—Methotrexate—esophageal cancer	0.000293	0.00551	CcSEcCtD
Flutamide—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000291	0.00546	CcSEcCtD
Flutamide—Decreased appetite—Cisplatin—esophageal cancer	0.000287	0.00539	CcSEcCtD
Flutamide—Drowsiness—Methotrexate—esophageal cancer	0.000284	0.00534	CcSEcCtD
Flutamide—CYP1A1—lymph node—esophageal cancer	0.000279	0.0136	CbGeAlD
Flutamide—Ill-defined disorder—Capecitabine—esophageal cancer	0.000277	0.0052	CcSEcCtD
Flutamide—Anaemia—Capecitabine—esophageal cancer	0.000276	0.00518	CcSEcCtD
Flutamide—Feeling abnormal—Cisplatin—esophageal cancer	0.000272	0.00511	CcSEcCtD
Flutamide—Haematuria—Methotrexate—esophageal cancer	0.000271	0.00509	CcSEcCtD
Flutamide—Malaise—Capecitabine—esophageal cancer	0.000269	0.00505	CcSEcCtD
Flutamide—Leukopenia—Capecitabine—esophageal cancer	0.000267	0.00501	CcSEcCtD
Flutamide—Hypertension—Capecitabine—esophageal cancer	0.000257	0.00484	CcSEcCtD
Flutamide—Hepatitis—Methotrexate—esophageal cancer	0.000255	0.00479	CcSEcCtD
Flutamide—Anxiety—Capecitabine—esophageal cancer	0.000253	0.00475	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000252	0.00474	CcSEcCtD
Flutamide—Discomfort—Capecitabine—esophageal cancer	0.000251	0.00471	CcSEcCtD
Flutamide—Confusional state—Capecitabine—esophageal cancer	0.000245	0.00461	CcSEcCtD
Flutamide—Oedema—Capecitabine—esophageal cancer	0.000243	0.00457	CcSEcCtD
Flutamide—Thrombocytopenia—Capecitabine—esophageal cancer	0.000238	0.00448	CcSEcCtD
Flutamide—Asthenia—Cisplatin—esophageal cancer	0.000237	0.00445	CcSEcCtD
Flutamide—Skin disorder—Capecitabine—esophageal cancer	0.000236	0.00444	CcSEcCtD
Flutamide—Anorexia—Capecitabine—esophageal cancer	0.000232	0.00436	CcSEcCtD
Flutamide—Diarrhoea—Cisplatin—esophageal cancer	0.000226	0.00424	CcSEcCtD
Flutamide—Erythema—Methotrexate—esophageal cancer	0.000222	0.00417	CcSEcCtD
Flutamide—Insomnia—Capecitabine—esophageal cancer	0.00022	0.00413	CcSEcCtD
Flutamide—Decreased appetite—Capecitabine—esophageal cancer	0.000212	0.00397	CcSEcCtD
Flutamide—Vomiting—Cisplatin—esophageal cancer	0.00021	0.00394	CcSEcCtD
Flutamide—Fatigue—Capecitabine—esophageal cancer	0.00021	0.00394	CcSEcCtD
Flutamide—Rash—Cisplatin—esophageal cancer	0.000208	0.00391	CcSEcCtD
Flutamide—Constipation—Capecitabine—esophageal cancer	0.000208	0.00391	CcSEcCtD
Flutamide—Dermatitis—Cisplatin—esophageal cancer	0.000208	0.00391	CcSEcCtD
Flutamide—Ill-defined disorder—Methotrexate—esophageal cancer	0.000206	0.00387	CcSEcCtD
Flutamide—Anaemia—Methotrexate—esophageal cancer	0.000205	0.00385	CcSEcCtD
Flutamide—Feeling abnormal—Capecitabine—esophageal cancer	0.000201	0.00377	CcSEcCtD
Flutamide—Malaise—Methotrexate—esophageal cancer	0.0002	0.00376	CcSEcCtD
Flutamide—Leukopenia—Methotrexate—esophageal cancer	0.000199	0.00373	CcSEcCtD
Flutamide—Nausea—Cisplatin—esophageal cancer	0.000196	0.00368	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000188	0.00353	CcSEcCtD
Flutamide—Discomfort—Methotrexate—esophageal cancer	0.000187	0.00351	CcSEcCtD
Flutamide—Confusional state—Methotrexate—esophageal cancer	0.000183	0.00343	CcSEcCtD
Flutamide—Thrombocytopenia—Methotrexate—esophageal cancer	0.000177	0.00333	CcSEcCtD
Flutamide—Skin disorder—Methotrexate—esophageal cancer	0.000176	0.00331	CcSEcCtD
Flutamide—Asthenia—Capecitabine—esophageal cancer	0.000175	0.00328	CcSEcCtD
Flutamide—Anorexia—Methotrexate—esophageal cancer	0.000173	0.00324	CcSEcCtD
Flutamide—Pruritus—Capecitabine—esophageal cancer	0.000172	0.00323	CcSEcCtD
Flutamide—Diarrhoea—Capecitabine—esophageal cancer	0.000167	0.00313	CcSEcCtD
Flutamide—Insomnia—Methotrexate—esophageal cancer	0.000164	0.00308	CcSEcCtD
Flutamide—Somnolence—Methotrexate—esophageal cancer	0.000161	0.00303	CcSEcCtD
Flutamide—Dizziness—Capecitabine—esophageal cancer	0.000161	0.00302	CcSEcCtD
Flutamide—Decreased appetite—Methotrexate—esophageal cancer	0.000158	0.00296	CcSEcCtD
Flutamide—Fatigue—Methotrexate—esophageal cancer	0.000156	0.00293	CcSEcCtD
Flutamide—Vomiting—Capecitabine—esophageal cancer	0.000155	0.00291	CcSEcCtD
Flutamide—Rash—Capecitabine—esophageal cancer	0.000153	0.00288	CcSEcCtD
Flutamide—Dermatitis—Capecitabine—esophageal cancer	0.000153	0.00288	CcSEcCtD
Flutamide—Headache—Capecitabine—esophageal cancer	0.000152	0.00286	CcSEcCtD
Flutamide—Feeling abnormal—Methotrexate—esophageal cancer	0.000149	0.0028	CcSEcCtD
Flutamide—Nausea—Capecitabine—esophageal cancer	0.000145	0.00272	CcSEcCtD
Flutamide—Asthenia—Methotrexate—esophageal cancer	0.00013	0.00244	CcSEcCtD
Flutamide—Pruritus—Methotrexate—esophageal cancer	0.000128	0.00241	CcSEcCtD
Flutamide—Diarrhoea—Methotrexate—esophageal cancer	0.000124	0.00233	CcSEcCtD
Flutamide—Dizziness—Methotrexate—esophageal cancer	0.00012	0.00225	CcSEcCtD
Flutamide—Vomiting—Methotrexate—esophageal cancer	0.000115	0.00216	CcSEcCtD
Flutamide—Rash—Methotrexate—esophageal cancer	0.000114	0.00215	CcSEcCtD
Flutamide—Dermatitis—Methotrexate—esophageal cancer	0.000114	0.00214	CcSEcCtD
Flutamide—Headache—Methotrexate—esophageal cancer	0.000114	0.00213	CcSEcCtD
Flutamide—Nausea—Methotrexate—esophageal cancer	0.000108	0.00202	CcSEcCtD
Flutamide—CYP1B1—Metabolism—PLCE1—esophageal cancer	5.51e-05	0.000355	CbGpPWpGaD
Flutamide—CYP1A2—Metapathway biotransformation—CYP19A1—esophageal cancer	5.49e-05	0.000354	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	5.47e-05	0.000352	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	5.44e-05	0.000351	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—esophageal cancer	5.43e-05	0.00035	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—esophageal cancer	5.43e-05	0.00035	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—TP53—esophageal cancer	5.42e-05	0.000349	CbGpPWpGaD
Flutamide—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	5.37e-05	0.000346	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	5.35e-05	0.000344	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	5.28e-05	0.00034	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—NOTCH1—esophageal cancer	5.05e-05	0.000325	CbGpPWpGaD
Flutamide—CYP1A1—PPARA activates gene expression—EP300—esophageal cancer	4.98e-05	0.000321	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—SLC52A3—esophageal cancer	4.97e-05	0.00032	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—BLVRB—esophageal cancer	4.97e-05	0.00032	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	4.95e-05	0.000319	CbGpPWpGaD
Flutamide—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—esophageal cancer	4.93e-05	0.000318	CbGpPWpGaD
Flutamide—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—esophageal cancer	4.87e-05	0.000314	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—ADH1B—esophageal cancer	4.83e-05	0.000311	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—SLC52A3—esophageal cancer	4.69e-05	0.000302	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—BLVRB—esophageal cancer	4.69e-05	0.000302	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	4.64e-05	0.000299	CbGpPWpGaD
Flutamide—AR—Gene Expression—PSME2—esophageal cancer	4.64e-05	0.000299	CbGpPWpGaD
Flutamide—AR—Gene Expression—PSME1—esophageal cancer	4.64e-05	0.000299	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—TYMP—esophageal cancer	4.61e-05	0.000297	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—CREBBP—esophageal cancer	4.57e-05	0.000295	CbGpPWpGaD
Flutamide—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	4.57e-05	0.000294	CbGpPWpGaD
Flutamide—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	4.51e-05	0.00029	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—CYP26A1—esophageal cancer	4.49e-05	0.000289	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	4.49e-05	0.000289	CbGpPWpGaD
Flutamide—AR—Gene Expression—NOTCH3—esophageal cancer	4.38e-05	0.000282	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—ALOX15—esophageal cancer	4.37e-05	0.000282	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	4.32e-05	0.000278	CbGpPWpGaD
Flutamide—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	4.3e-05	0.000277	CbGpPWpGaD
Flutamide—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	4.24e-05	0.000273	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CA1—esophageal cancer	4.22e-05	0.000272	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—SLC10A2—esophageal cancer	4.22e-05	0.000272	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	4.19e-05	0.00027	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—GSTO1—esophageal cancer	4.17e-05	0.000269	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—TPI1—esophageal cancer	4.17e-05	0.000269	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—ALDOB—esophageal cancer	4e-05	0.000258	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—SLC10A2—esophageal cancer	3.99e-05	0.000257	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CA1—esophageal cancer	3.99e-05	0.000257	CbGpPWpGaD
Flutamide—AR—Gene Expression—NOTCH2—esophageal cancer	3.92e-05	0.000253	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CA2—esophageal cancer	3.86e-05	0.000249	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	3.86e-05	0.000249	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—GAPDH—esophageal cancer	3.85e-05	0.000248	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—SLC52A3—esophageal cancer	3.84e-05	0.000247	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—BLVRB—esophageal cancer	3.84e-05	0.000247	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—CRABP1—esophageal cancer	3.82e-05	0.000246	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CA2—esophageal cancer	3.65e-05	0.000235	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—GNG7—esophageal cancer	3.63e-05	0.000234	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PLCE1—esophageal cancer	3.59e-05	0.000231	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ADH7—esophageal cancer	3.59e-05	0.000231	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	3.57e-05	0.00023	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	3.43e-05	0.000221	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—ALDH2—esophageal cancer	3.4e-05	0.000219	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PLCE1—esophageal cancer	3.39e-05	0.000219	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ADH7—esophageal cancer	3.39e-05	0.000219	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	3.37e-05	0.000217	CbGpPWpGaD
Flutamide—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—esophageal cancer	3.36e-05	0.000216	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	3.35e-05	0.000216	CbGpPWpGaD
Flutamide—AR—Gene Expression—SMAD4—esophageal cancer	3.3e-05	0.000212	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CA1—esophageal cancer	3.26e-05	0.00021	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—SLC10A2—esophageal cancer	3.26e-05	0.00021	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—GSTT1—esophageal cancer	3.24e-05	0.000209	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—CYP2A6—esophageal cancer	3.2e-05	0.000206	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	3.19e-05	0.000205	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ADH1B—esophageal cancer	3.15e-05	0.000203	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—ENO1—esophageal cancer	3.03e-05	0.000195	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PTGS1—esophageal cancer	3.03e-05	0.000195	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—TYMP—esophageal cancer	3.01e-05	0.000194	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—BLVRB—esophageal cancer	2.99e-05	0.000193	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—SLC52A3—esophageal cancer	2.99e-05	0.000193	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PSME2—esophageal cancer	2.99e-05	0.000193	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PSME1—esophageal cancer	2.99e-05	0.000193	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CA2—esophageal cancer	2.99e-05	0.000192	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ADH1B—esophageal cancer	2.97e-05	0.000192	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CYP26A1—esophageal cancer	2.93e-05	0.000189	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	2.92e-05	0.000188	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ALOX15—esophageal cancer	2.85e-05	0.000184	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—TYMP—esophageal cancer	2.84e-05	0.000183	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PLCE1—esophageal cancer	2.78e-05	0.000179	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ADH7—esophageal cancer	2.78e-05	0.000179	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CYP26A1—esophageal cancer	2.76e-05	0.000178	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	2.74e-05	0.000177	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—TPI1—esophageal cancer	2.72e-05	0.000175	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GSTO1—esophageal cancer	2.72e-05	0.000175	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—MYC—esophageal cancer	2.71e-05	0.000175	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ALOX15—esophageal cancer	2.69e-05	0.000174	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	2.67e-05	0.000172	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.61e-05	0.000168	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ALDOB—esophageal cancer	2.61e-05	0.000168	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GSTO1—esophageal cancer	2.57e-05	0.000166	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—TPI1—esophageal cancer	2.57e-05	0.000166	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CA1—esophageal cancer	2.54e-05	0.000164	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—SLC10A2—esophageal cancer	2.54e-05	0.000164	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GAPDH—esophageal cancer	2.51e-05	0.000162	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CRABP1—esophageal cancer	2.49e-05	0.00016	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ALDOB—esophageal cancer	2.46e-05	0.000159	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ADH1B—esophageal cancer	2.43e-05	0.000157	CbGpPWpGaD
Flutamide—AR—Gene Expression—NOTCH1—esophageal cancer	2.43e-05	0.000157	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—CYP19A1—esophageal cancer	2.42e-05	0.000156	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GAPDH—esophageal cancer	2.37e-05	0.000153	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GNG7—esophageal cancer	2.37e-05	0.000153	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CRABP1—esophageal cancer	2.35e-05	0.000151	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CA2—esophageal cancer	2.33e-05	0.00015	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—TYMP—esophageal cancer	2.33e-05	0.00015	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—BLVRB—esophageal cancer	2.31e-05	0.000149	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—SLC52A3—esophageal cancer	2.31e-05	0.000149	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	2.27e-05	0.000147	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CYP26A1—esophageal cancer	2.26e-05	0.000146	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GNG7—esophageal cancer	2.24e-05	0.000144	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ALDH2—esophageal cancer	2.22e-05	0.000143	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—HMOX1—esophageal cancer	2.21e-05	0.000143	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ALOX15—esophageal cancer	2.2e-05	0.000142	CbGpPWpGaD
Flutamide—AR—Gene Expression—CREBBP—esophageal cancer	2.2e-05	0.000142	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.17e-05	0.00014	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PLCE1—esophageal cancer	2.16e-05	0.000139	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ADH7—esophageal cancer	2.16e-05	0.000139	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	2.14e-05	0.000138	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—ABCB1—esophageal cancer	2.12e-05	0.000137	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GSTT1—esophageal cancer	2.11e-05	0.000136	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—TPI1—esophageal cancer	2.1e-05	0.000136	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GSTO1—esophageal cancer	2.1e-05	0.000136	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ALDH2—esophageal cancer	2.1e-05	0.000135	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CYP2A6—esophageal cancer	2.09e-05	0.000134	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ALDOB—esophageal cancer	2.02e-05	0.00013	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GSTT1—esophageal cancer	1.99e-05	0.000128	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ENO1—esophageal cancer	1.98e-05	0.000127	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PTGS1—esophageal cancer	1.98e-05	0.000127	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CYP2A6—esophageal cancer	1.97e-05	0.000127	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CA1—esophageal cancer	1.96e-05	0.000126	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—SLC10A2—esophageal cancer	1.96e-05	0.000126	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.96e-05	0.000126	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PSME2—esophageal cancer	1.95e-05	0.000126	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PSME1—esophageal cancer	1.95e-05	0.000126	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GAPDH—esophageal cancer	1.94e-05	0.000125	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CRABP1—esophageal cancer	1.92e-05	0.000124	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ADH1B—esophageal cancer	1.9e-05	0.000122	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ENO1—esophageal cancer	1.87e-05	0.00012	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PTGS1—esophageal cancer	1.87e-05	0.00012	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PSME1—esophageal cancer	1.84e-05	0.000119	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PSME2—esophageal cancer	1.84e-05	0.000119	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GNG7—esophageal cancer	1.83e-05	0.000118	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—TYMP—esophageal cancer	1.81e-05	0.000117	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CA2—esophageal cancer	1.8e-05	0.000116	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CYP26A1—esophageal cancer	1.76e-05	0.000114	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ALOX15—esophageal cancer	1.72e-05	0.000111	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ALDH2—esophageal cancer	1.71e-05	0.00011	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CYP1B1—esophageal cancer	1.68e-05	0.000108	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PLCE1—esophageal cancer	1.67e-05	0.000108	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ADH7—esophageal cancer	1.67e-05	0.000108	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GSTO1—esophageal cancer	1.64e-05	0.000106	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—TPI1—esophageal cancer	1.64e-05	0.000106	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GSTT1—esophageal cancer	1.63e-05	0.000105	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CYP2A6—esophageal cancer	1.61e-05	0.000104	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.61e-05	0.000104	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.61e-05	0.000103	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.61e-05	0.000103	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CYP1B1—esophageal cancer	1.59e-05	0.000102	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CYP19A1—esophageal cancer	1.58e-05	0.000102	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ALDOB—esophageal cancer	1.57e-05	0.000101	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PTGS1—esophageal cancer	1.53e-05	9.85e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ENO1—esophageal cancer	1.53e-05	9.85e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GAPDH—esophageal cancer	1.51e-05	9.75e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PSME2—esophageal cancer	1.51e-05	9.7e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PSME1—esophageal cancer	1.51e-05	9.7e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CRABP1—esophageal cancer	1.5e-05	9.66e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CYP19A1—esophageal cancer	1.49e-05	9.62e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ADH1B—esophageal cancer	1.46e-05	9.43e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—HMOX1—esophageal cancer	1.44e-05	9.29e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GNG7—esophageal cancer	1.43e-05	9.19e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—CREBBP—esophageal cancer	1.42e-05	9.15e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—TYMP—esophageal cancer	1.4e-05	9.01e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ABCB1—esophageal cancer	1.38e-05	8.92e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—HMOX1—esophageal cancer	1.36e-05	8.78e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CYP26A1—esophageal cancer	1.36e-05	8.77e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.34e-05	8.61e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ALDH2—esophageal cancer	1.34e-05	8.61e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ALOX15—esophageal cancer	1.33e-05	8.54e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.32e-05	8.47e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ABCB1—esophageal cancer	1.31e-05	8.43e-05	CbGpPWpGaD
Flutamide—AR—Gene Expression—MYC—esophageal cancer	1.31e-05	8.42e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CYP1B1—esophageal cancer	1.3e-05	8.37e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GSTT1—esophageal cancer	1.27e-05	8.19e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—NOS3—esophageal cancer	1.27e-05	8.19e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—TPI1—esophageal cancer	1.26e-05	8.15e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GSTO1—esophageal cancer	1.26e-05	8.15e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CYP2A6—esophageal cancer	1.26e-05	8.09e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.25e-05	8.06e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CYP19A1—esophageal cancer	1.22e-05	7.87e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ALDOB—esophageal cancer	1.21e-05	7.81e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ENO1—esophageal cancer	1.19e-05	7.67e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PTGS1—esophageal cancer	1.19e-05	7.67e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PSME2—esophageal cancer	1.17e-05	7.56e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PSME1—esophageal cancer	1.17e-05	7.56e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GAPDH—esophageal cancer	1.17e-05	7.52e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PTGS2—esophageal cancer	1.16e-05	7.49e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CRABP1—esophageal cancer	1.16e-05	7.45e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—HMOX1—esophageal cancer	1.11e-05	7.18e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GNG7—esophageal cancer	1.1e-05	7.09e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.09e-05	7.05e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ABCB1—esophageal cancer	1.07e-05	6.9e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ALDH2—esophageal cancer	1.03e-05	6.64e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.02e-05	6.6e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CYP1B1—esophageal cancer	1.01e-05	6.52e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	9.89e-06	6.37e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GSTT1—esophageal cancer	9.81e-06	6.32e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CYP2A6—esophageal cancer	9.69e-06	6.25e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—EP300—esophageal cancer	9.67e-06	6.23e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CYP19A1—esophageal cancer	9.52e-06	6.13e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CREBBP—esophageal cancer	9.25e-06	5.96e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ENO1—esophageal cancer	9.19e-06	5.92e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PTGS1—esophageal cancer	9.19e-06	5.92e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PSME2—esophageal cancer	9.06e-06	5.84e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PSME1—esophageal cancer	9.06e-06	5.84e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CREBBP—esophageal cancer	8.74e-06	5.63e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—HMOX1—esophageal cancer	8.69e-06	5.6e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	8.52e-06	5.49e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ABCB1—esophageal cancer	8.34e-06	5.37e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—NOS3—esophageal cancer	8.28e-06	5.34e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	8.09e-06	5.21e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—NOS3—esophageal cancer	7.82e-06	5.04e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CYP1B1—esophageal cancer	7.81e-06	5.04e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PTGS2—esophageal cancer	7.58e-06	4.88e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CYP19A1—esophageal cancer	7.35e-06	4.73e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PTGS2—esophageal cancer	7.16e-06	4.61e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CREBBP—esophageal cancer	7.15e-06	4.61e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PIK3CA—esophageal cancer	7.15e-06	4.61e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—HMOX1—esophageal cancer	6.7e-06	4.32e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ABCB1—esophageal cancer	6.43e-06	4.15e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—NOS3—esophageal cancer	6.4e-06	4.13e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	6.3e-06	4.06e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—EP300—esophageal cancer	6.3e-06	4.06e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—EP300—esophageal cancer	5.95e-06	3.84e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PTGS2—esophageal cancer	5.86e-06	3.77e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CREBBP—esophageal cancer	5.57e-06	3.59e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—NOS3—esophageal cancer	4.99e-06	3.22e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—EP300—esophageal cancer	4.87e-06	3.14e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PIK3CA—esophageal cancer	4.66e-06	3e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PTGS2—esophageal cancer	4.56e-06	2.94e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PIK3CA—esophageal cancer	4.4e-06	2.84e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CREBBP—esophageal cancer	4.3e-06	2.77e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—NOS3—esophageal cancer	3.85e-06	2.48e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—EP300—esophageal cancer	3.8e-06	2.45e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PIK3CA—esophageal cancer	3.6e-06	2.32e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PTGS2—esophageal cancer	3.52e-06	2.27e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—EP300—esophageal cancer	2.93e-06	1.89e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PIK3CA—esophageal cancer	2.81e-06	1.81e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PIK3CA—esophageal cancer	2.17e-06	1.4e-05	CbGpPWpGaD
